World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
56
Citations
8175
World Ranking
11931
National Ranking
3203

Tarek S. Mansour publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Tarek S. Mansour sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 217 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Tarek S. Mansour D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Tarek S. Mansour sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 56 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Tarek S. Mansour is affiliated with Pfizer in the United States and specializes in the field of Medicine, with a focus on several key subfields including Infectious Diseases, Oncology, Surgery, Epidemiology, and Organic Chemistry. Their research spans a variety of topics related to both clinical and biochemical aspects of health and disease.

The primary topics of Mansour's work include:

  • COVID-19 and healthcare impacts
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Childhood Cancer Survivors' Quality of Life
  • Pancreatitis Pathology and Treatment
  • Liver Disease Diagnosis and Treatment
  • Iron Metabolism and Disorders

Their contributions have appeared frequently in several publication venues, most notably:

  • Clinical Lymphoma Myeloma & Leukemia
  • Egyptian Liver Journal
  • Journal of Minimally Invasive Gynecology
  • Journal of Pharmacy And Bioallied Sciences
  • Bioorganic & Medicinal Chemistry Letters

Mansour has collaborated extensively with a number of coauthors, including:

  • Mahmoud Hammad
  • Sonia Soliman
  • Reem Hassan
  • Lobna Shalaby
  • Sherif Abouelnaga

Their recent published papers reflect a range of research interests:

  • "Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country" (2021), Clinical Lymphoma Myeloma & Leukemia
  • "Updates in drug-induced acute pancreatitis" (2020), Egyptian Liver Journal
  • "Potent dual EGFR/Her4 tyrosine kinase inhibitors containing novel (1,2-dithiolan-4-yl)acetamides" (2020), Bioorganic & Medicinal Chemistry Letters
  • "CNS Demyelination Syndromes Following COVID-19 Vaccination: A Case Series" (2024), Journal of Pharmacy And Bioallied Sciences
  • "Potent, Gut-Restricted Inhibitors of Divalent Metal Transporter 1: Preclinical Efficacy against Iron Overload and Safety Evaluation" (2023), Journal of Pharmacology and Experimental Therapeutics

Their work covers clinical research related to infectious diseases such as COVID-19, investigations into the pathology and treatment of pancreatitis, studies on iron metabolism disorders, and oncology-related drug development, reflecting a multidisciplinary approach spanning both clinical and experimental biomedical research.

Best Publications

  • Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin.

    Ker Yu;Lourdes Toral-Barza;Celine Shi;Wei-Guo Zhang

  • Bis(morpholino-1,3,5-triazine) derivatives: potent adenosine 5'-triphosphate competitive phosphatidylinositol-3-kinase/mammalian target of rapamycin inhibitors: discovery of compound 26 (PKI-587), a highly efficacious dual inhibitor.

    Aranapakam M. Venkatesan;Christoph M. Dehnhardt;Efren Delos Santos;Zecheng Chen

  • Acidity measurements on pyridines in tetrahydrofuran using lithiated silylamines

    Unknown

  • Design and synthesis of monocyclic β-lactams as mechanism-based inhibitors of human cytomegalovirus protease

    Alan D. Borthwick;Gordon Weingarten;Terry M. Haley;Mirek Tomaszewski

  • Kinase domain mutations in cancer: implications for small molecule drug design strategies.

    Jack A Bikker;Natasja Brooijmans;Allan Wissner;Tarek S Mansour

  • Structure-Based Optimization of Protein Tyrosine Phosphatase 1B Inhibitors: From the Active Site to the Second Phosphotyrosine Binding Site

    Douglas P Wilson;Zhao-Kui Wan;Wei-Xin Xu;Steven J Kirincich

  • Molecular mechanism of hepatitis C virus replicon variants with reduced susceptibility to a benzofuran inhibitor, HCV-796.

    Anita Y. M. Howe;Huiming Cheng;Stephen Johann;Stanley Mullen

  • PROCESS FOR STEREOSELECTIVE SYNTHESIS OF NUCLEOSIDES DERIVATIVES

    Mansour Tarek;Tse Allan H

  • A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).

    Wei Li;Jianchang Li;Yuchuan Wu;Junjun Wu

  • ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin: Design and Synthesis of Highly Potent and Selective Pyrazolopyrimidines.

    Arie Zask;Jeroen C. Verheijen;Kevin Curran;Joshua Kaplan

  • β-Keto sulfones as inhibitors of 11β-hydroxysteroid dehydrogenase type I and the mechanism of action

    Jason Xiang;Manus Ipek;Vipin Suri;May Tam

  • Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors

    Ariamala Gopalsamy;Kitae Lim;Gregory Ciszewski;Kaapjoo Park

  • The scope and mechanism of phosphonium-mediated S(N)Ar reactions in heterocyclic amides and ureas.

    Zhao-Kui Wan;Sumrit Wacharasindhu;Christopher G. Levins;Melissa Lin

  • An efficient direct amination of cyclic amides and cyclic ureas.

    Zhao-Kui Wan;Sumrit Wacharasindhu;Eva Binnun;Tarek Mansour

  • Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4.

    Hwei-Ru Tsou;Xiaoxiang Liu;Gary Birnberg;Joshua Kaplan

  • Anti-human immunodeficiency virus and anti-hepatitis-B virus activities and toxicities of the enantiomers of 2'-deoxy-3'-oxa-4'-thiocytidine and their 5-fluoro analogues in vitro.

    Tarek S. Mansour;Haolun Jin;Wei Wang;Elizabeth U. Hooker

  • Phenyl thiazolyl urea and carbamate derivatives as new inhibitors of bacterial cell-wall biosynthesis.

    Gerardo D. Francisco;Zhong Li;J.Donald Albright;Nancy H. Eudy

  • Lead Optimization of N-3-Substituted 7-Morpholinotriazolopyrimidines as Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of PKI-402

    Christoph M. Dehnhardt;Aranapakam M. Venkatesan;Efren Delos Santos;Zecheng Chen

  • Acidity measurements in THF. V. Heteroaromatic compounds containing 5-membered rings

    Unknown

  • 2,4-Diamino-quinazolines as inhibitors of β-catenin/Tcf-4 pathway: Potential treatment for colorectal cancer

    Zecheng Chen;Aranapakam M. Venkatesan;Christoph M. Dehnhardt;Osvaldo Dos Santos

  • Processes for preparing substituted 1,3-oxathiolanes with antiviral properties

    Bernard Belleau;Tarek Mansour;Allan Tse;Colleen A. Evans

  • Anti-Human Immunodeficiency Virus Type 1 Activity, Intracellular Metabolism, and Pharmacokinetic Evaluation of 2′-Deoxy-3′-Oxa-4′-Thiocytidine

    J M de Muys;H Gourdeau;N Nguyen-Ba;D L Taylor

Frequent Co-Authors

Robert T. Abraham
Robert T. Abraham Pfizer (United States)
Mark A. Wainberg
Mark A. Wainberg McGill University
Patricia A. Bradford
Patricia A. Bradford AstraZeneca (United Kingdom)
Weiguo Zhang
Weiguo Zhang Duke University
James Tobin
James Tobin Yale University
Brent E. Korba
Brent E. Korba Georgetown University
Robert A. Bonomo
Robert A. Bonomo Case Western Reserve University
Marc S. Collett
Marc S. Collett Takeda (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in expanding their expertise beyond traditional chemistry, forensic science offers a compelling interdisciplinary route. Many of the best online colleges for forensic science provide affordable programs that blend chemistry with criminal investigation techniques.

Advanced studies such as an online forensic psychology masters degree can further enhance understanding of the behavioral aspects behind criminal acts, complementing scientific analysis skills acquired in chemistry.

Considering career options is crucial. The field of forensic science offers varied roles with competitive compensation, which you can explore through detailed insights on forensic career paths and salary. This helps in aligning education choices with future job prospects.

It’s important to also factor in the financial commitment. Many prospective students evaluate the costs when selecting a program, so reviewing data on how much is criminal justice degree can guide informed decisions about affordability and investment returns in related disciplines.

Best Scientists Citing Tarek S. Mansour

Trending Scientists